Table 4. Summary of evaluation design for the moderate and stronger campaign evaluations.
| Health topic (number of campaigns per topic) | n | Moderate evaluation | Stronger evaluation | Low exposure: 0–30% | Moderate exposure: 31–60% | High exposure: 61–100% | Probability sample | Sample size: 1,000+ | Statistical controls | Advanced statistical methods | Effect of exposure | Change over time | Difference between treatment/control | Observed effect on intermediary outcomes | Observed effect on behavior | Observed effect on health outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diarrheal disease | 13 | 10 | 3 | 5 | 2 | 5 | 13 | 11 | 8 | 1 | 3 | 12 | 2 | 6 | 10 | 0 |
| Immunization | 7 | 3 | 4 | 3 | 2 | 2 | 7 | 6 | 6 | 2 | 2 | 6 | 0 | 2 | 5 | 0 |
| Malaria | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 |
| Nutrition | 9 | 3 | 6 | 1 | 5 | 1 | 5 | 3 | 6 | 3 | 3 | 9 | 2 | 5 | 8 | 1 |
| PMTCT | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
| Respiratory diseases | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
| All child survival | 32 | 14 44% | 9 28% | 10 31% | 10 31% | 26 81% | 21 66% | 22 69% | 7 22% | 9 28% | 29 91% | 5 16% | 13 41% | 26 81% | 1 3% | |
| Reproductive health | 46 | 14 30% | 32 70% | 9 20% | 16 35% | 20 43% | 41 89% | 33 72% | 36 78% | 13 28% | 31 67% | 28 61% | 9 20% | 28 61% | 41 89% | 0 0% |
| Note. PMTCT = preventing mother-to-child transmission. | ||||||||||||||||